Key Points
NPL.SI stock volume surges 53x to 170,000 shares in pre-market trading.
Stock maintains S$0.23 price with S$29.9M market cap on SES.
Niks Professional Ltd shows 23% net income growth but faces long-term revenue headwinds.
Company offers 100% dividend yield with B-grade HOLD rating from Meyka AI.
Niks Professional Ltd (NPL.SI) is experiencing notable trading activity in pre-market hours on May 12, 2026. The stock has recorded a volume spike of 170,000 shares, significantly above its typical daily average of 3,200 shares. This represents a relative volume of 53.1x, indicating heightened investor interest in the Singapore-listed healthcare company. NPL.SI stock remains stable at S$0.23 on the Singapore Exchange (SES), with a market capitalization of S$29.9 million. The volume surge suggests increased market attention on the dermatology and aesthetic medical services provider, which operates the NIKS brand across Singapore.
NPL.SI Stock Price Action and Volume Dynamics
NPL.SI stock is trading at S$0.23 with zero price movement today, maintaining its previous close. The 170,000 share volume represents exceptional activity compared to the 3,200-share average. This volume spike indicates strong institutional or retail interest despite price stability. The stock’s 52-week range spans from S$0.115 to S$0.23, showing the current price sits at the upper end of recent trading levels.
The relative volume of 53.1x is a critical metric for pre-market analysis. Such elevated volume often precedes significant price moves or reflects news-driven trading. Track NPL.SI on Meyka for real-time updates on volume patterns and price movements throughout the trading session.
Market Sentiment and Trading Activity
Trading Activity
The pre-market volume surge suggests investors are positioning ahead of the regular market open. NPL.SI stock’s average volume of 3,200 shares typically reflects limited daily liquidity. Today’s spike to 170,000 shares indicates either accumulation or distribution activity. The 50-day moving average sits at S$0.2254, slightly above current levels, while the 200-day average is S$0.20292.
Liquidation
No significant liquidation signals appear in the current data. The stock maintains a strong current ratio of 5.31x, indicating solid short-term liquidity. Interest coverage stands at 33.05x, showing the company can easily service debt obligations. The volume spike appears driven by positive sentiment rather than forced selling or distressed trading.
Niks Professional Ltd Fundamentals and Valuation
Niks Professional Ltd operates three business segments: Clinics, Retail, and Headquarters. The company provides family practice dermatology, aesthetic medical services, and medical skincare products across Singapore. With 620 full-time employees, NPL.SI stock reflects a healthcare company focused on non-invasive treatments including laser therapy and injectables.
The valuation metrics show NPL.SI stock trades at a P/E ratio of 23.0x with earnings per share of S$0.01. The price-to-book ratio stands at 1.53x, suggesting moderate valuation relative to book value. Dividend yield reaches 100% based on a S$0.23 dividend per share, though this reflects the company’s capital return strategy. Revenue per share is S$0.0867, indicating modest top-line generation relative to market cap.
Growth Prospects and Financial Performance
NPL.SI stock shows mixed growth signals. Revenue growth reached 3.1% year-over-year, while net income grew 23.3%. Earnings per share increased 23.1%, demonstrating improving profitability despite modest revenue expansion. Gross profit surged 151.5%, indicating strong operational leverage and margin improvement.
However, long-term trends present challenges. Three-year revenue growth per share declined 4.4%, and net income per share fell 37.7% over the same period. Operating cash flow growth was positive at 16.8%, while free cash flow declined 7.4%. These metrics suggest NPL.SI stock faces headwinds in sustaining growth momentum beyond recent quarters.
Final Thoughts
The 170,000 share volume spike in NPL.SI stock pre-market trading signals renewed investor attention on Niks Professional Ltd. The stock maintains stability at S$0.23 while trading activity surges 53x above average levels. Fundamentally, the company shows improving profitability with 23% net income growth, though long-term revenue trends remain concerning. The healthcare sector continues attracting defensive investors seeking dividend income, with NPL.SI offering a 100% yield. Investors should monitor whether today’s volume translates into sustained price momentum or represents profit-taking ahead of earnings announcements. The company’s focus on aesthetic dermatology positions it…
FAQs
The spike represents 53x normal activity, indicating institutional positioning or retail interest. Pre-market surges often precede significant price moves or reflect sector-wide healthcare trading activity.
NPL.SI trades at S$0.23 with a market cap of S$29.9 million. The 52-week range is S$0.115–S$0.23, with trading near recent support levels.
NPL.SI offers a 100% dividend yield at S$0.23 per share, reflecting capital return rather than sustainable earnings. Verify dividend sustainability before investing.
Niks Professional Ltd provides family practice dermatology and aesthetic medical services in Singapore, including acne treatment, laser therapy, injectables, and medical skincare products.
Meyka AI rates NPL.SI as B with a HOLD recommendation (score: 63.56), factoring in sector performance, financial growth, and analyst consensus. Not financial advice.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)